Anti-microbial photodynamic therapy: useful in the future?
- PMID: 17120167
- DOI: 10.1007/s10103-006-0409-7
Anti-microbial photodynamic therapy: useful in the future?
Abstract
Previous chapters in this volume have focused on fundamental principles and clinical applications of PDT. This chapter will attempt to outline emerging areas of research to identify some new applications that may become useful in the future in clinical practise. The worldwide rise in antibiotic resistance has driven research to the development of novel anti-microbial strategies. Cutaneous diseases caused by MRSA are ideally suited to treatment by anti-microbial photodynamic therapy for eradicating localized infections and for modulating wound healing due to the ability to deliver photosensitizer and light with topical application. The use of photosensitizer and light as an anti-microbial agent against periodontal microbial biofilms should also represent an attractive method of eliminating oral bacteria. Suitable light sources, laser light and non-coherent light will be briefly covered. This chapter will focus on some aspects of anti-microbial photodynamic therapy that appear to be promising for dermatological indications and inactivation of pathogenic bacteria within the oral cavity.
Similar articles
-
Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model.Lasers Surg Med. 2010 Jan;42(1):38-44. doi: 10.1002/lsm.20887. Lasers Surg Med. 2010. PMID: 20077489 Free PMC article.
-
A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment.Mini Rev Med Chem. 2009 Jul;9(8):974-83. doi: 10.2174/138955709788681582. Mini Rev Med Chem. 2009. PMID: 19601890 Review.
-
Photodynamic antimicrobial activity of new porphyrin derivatives against methicillin resistant Staphylococcus aureus.J Microbiol. 2018 Nov;56(11):828-837. doi: 10.1007/s12275-018-8244-7. Epub 2018 Oct 24. J Microbiol. 2018. PMID: 30353469
-
Photodynamic inactivation of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus with Ru(II)-based type I/type II photosensitizers.Photodiagnosis Photodyn Ther. 2013 Dec;10(4):615-25. doi: 10.1016/j.pdpdt.2013.07.001. Epub 2013 Aug 5. Photodiagnosis Photodyn Ther. 2013. PMID: 24284119
-
Photodynamic therapy of microbial infections: state of the art and perspectives.J Environ Pathol Toxicol Oncol. 2006;25(1-2):505-19. doi: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.320. J Environ Pathol Toxicol Oncol. 2006. PMID: 16566738 Review.
Cited by
-
Optical method for monitoring of photodynamic inactivation of bacteria.J Biol Phys. 2011 Jan;37(1):107-16. doi: 10.1007/s10867-010-9202-8. Epub 2010 Sep 25. J Biol Phys. 2011. PMID: 22210965 Free PMC article.
-
Efficient photodynamic therapy against gram-positive and gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength.PLoS One. 2010 Jul 20;5(7):e11674. doi: 10.1371/journal.pone.0011674. PLoS One. 2010. PMID: 20652031 Free PMC article.
-
Dentition Type as a Determinant of Microbial Load Reduction by Antimicrobial Photodynamic Therapy in Deep Dentin Caries: A Systematic Review and Meta-analysis.J Dent (Shiraz). 2024 Dec 1;25(4):296-308. doi: 10.30476/dentjods.2023.98616.2098. eCollection 2024 Dec. J Dent (Shiraz). 2024. PMID: 39713109 Free PMC article. Review.
-
Focused role of nanoparticles against COVID-19: Diagnosis and treatment.Photodiagnosis Photodyn Ther. 2021 Jun;34:102287. doi: 10.1016/j.pdpdt.2021.102287. Epub 2021 Apr 6. Photodiagnosis Photodyn Ther. 2021. PMID: 33836276 Free PMC article. Review.
-
Inactivation of Aggregatibacter actinomycetemcomitans by two different modalities of photodynamic therapy using Toluidine blue O or Radachlorin as photosensitizers: an in vitro study.Lasers Med Sci. 2015 Jan;30(1):89-94. doi: 10.1007/s10103-014-1621-5. Epub 2014 Jul 1. Lasers Med Sci. 2015. PMID: 24981641
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources